A topical composition for nociceptive and neuropathic pain relief comprising one or more of menthol, camphor, methyl sulfonyl methane, lidocaine, Arinica montana, harpagophytum tincture, Emu oil, maqui powder, turmeric oil and in some embodiments methyl salicylate or capsaicin with Cannabis sativa.

A topical composition for nociceptive and neuropathic pain relief comprising one or more of menthol, camphor, methyl sulfonyl methane, lidocaine, Arinica montana, harpagophytum tincture, Emu oil, maqui powder, turmeric oil and in some embodiments methyl salicylate or capsaicin with Cannabis sativa.

The disclosed wound-healing formulation adds ingredients from the group consisting of camphor, menthol and eucalyptus to known silver sulfadiazine-based formulations, or to known silver sulfadiazine-and-urogastrone-based formulations, preferably for the topical treatment of skin wounds such as cuts, burns, surgical wounds, etc. Preferred embodiments are in cream form. The disclosed formulation shows unexpected and startling improvement in wound healing rates over expected healing rates using the known silver sulfadiazine-based or silver sulfadiazine-and-urogastrone-based formulations alone.

The disclosed wound-healing formulation adds ingredients from the group consisting of camphor, menthol and eucalyptus to known silver sulfadiazine-based formulations, or to known silver sulfadiazine-and-urogastrone-based formulations, preferably for the topical treatment of skin wounds such as cuts, burns, surgical wounds, etc. Preferred embodiments are in cream form. The disclosed formulation shows unexpected and startling improvement in wound healing rates over expected healing rates using the known silver sulfadiazine-based or silver sulfadiazine-and-urogastrone-based formulations alone.

The present invention includes composition and methods for treating inflammation and/or pain, the composition comprising: hemp cannabidiol (cannabinoid) 0.1%-0.6% weight percent; menthol 3.0-4.0% weight percent; arnica montana 0.1-5.0% weight percent; camphor 0.1-5.0% weight percent; bosweila serrata extract 0.1-5.0% weight percent; camphor terpene 0.1-5.0% weight percent; isopropyl alcohol <30% weight percent; glycerin <6.0% weight percent; and qs with water.

The present invention includes composition and methods for treating inflammation and/or pain, the composition comprising: hemp cannabidiol (cannabinoid) 0.1%-0.6% weight percent; menthol 3.0-4.0% weight percent; arnica montana 0.1-5.0% weight percent; camphor 0.1-5.0% weight percent; bosweila serrata extract 0.1-5.0% weight percent; camphor terpene 0.1-5.0% weight percent; isopropyl alcohol <30% weight percent; glycerin <6.0% weight percent; and qs with water.

A comfort article may comprise a proximal layer that adheres to the skin of a foot, and a non-slip distal layer with a high coefficient of friction that prevents footwear from sliding with respect to the foot without adhering to or sticking to the shoe. The proximal layer comprises a sticky adhesive surface or dry adhesive. The comfort article is cutout into various shapes and applied to one or more locations on a user's foot at a point of contact within the shoe that is intended to prevent the foot from moving with respect to the shoe. The comfort articles may also be supplied as a kit with various precut devices configured to fit certain types of footwear and accommodate user preferences. A cushion layer(s) may be interposed between the proximal layer and distal layer.

A comfort article may comprise a proximal layer that adheres to the skin of a foot, and a non-slip distal layer with a high coefficient of friction that prevents footwear from sliding with respect to the foot without adhering to or sticking to the shoe. The proximal layer comprises a sticky adhesive surface or dry adhesive. The comfort article is cutout into various shapes and applied to one or more locations on a user's foot at a point of contact within the shoe that is intended to prevent the foot from moving with respect to the shoe. The comfort articles may also be supplied as a kit with various precut devices configured to fit certain types of footwear and accommodate user preferences. A cushion layer(s) may be interposed between the proximal layer and distal layer.

The present invention relates to matrix adhesive patch and its preparation. The present invention specifically relates to an analgesic matrix adhesive patch and its preparation. The present invention more specifically relates to a matrix patch adhesive preparation containing Camphor, Menthol and Methyl salicylate and process for the preparation thereof which delivers predetermined amount of drug continuously through skin and provide the temporary relief of minor aches & pains of muscles & joints associated with; Arthritis, Strains, Bruises & Sprains.

The present invention relates to matrix adhesive patch and its preparation. The present invention specifically relates to an analgesic matrix adhesive patch and its preparation. The present invention more specifically relates to a matrix patch adhesive preparation containing Camphor, Menthol and Methyl salicylate and process for the preparation thereof which delivers predetermined amount of drug continuously through skin and provide the temporary relief of minor aches & pains of muscles & joints associated with; Arthritis, Strains, Bruises & Sprains.